John Stofko, MPH
Associate Professor of Pharmaceutical and Health Economics · USC School of Pharmacy
A healthcare industry executive with 30+ years of diverse experiences in biopharmaceutical clinical development.
Biopharmaceutical Clinical Development Biotech/Pharmaceutical Healthcare Consulting Executive Leadership Sales and Marketing
Edik Rafailov
Professor (Research), AIPT · Aston University
Prof Rafailov current research interests include CW and ultrashort-pulse lasers; generation of light from UV to THz and biomedical photonics
Biomedical Photonics Nanostructures Ultrashort-Pulse Lasers Photonics THz Radiation
Prof. Roman Prymula
Director · University Hospital, University of Defence
Dr. Prymula is involved in various research activities in preventive medicine, including clinical development of new vaccines
Vaccination COVID-19 Infectious Diseases Vaccines Medical Microbiology
Dr. Jean-Pierre Michel
Professor of Geriatric Medicine · Geneva University
Dr. Jean-Pierre Michel is a full Professor of Medicine at Geneva University Medical School and head of the geriatric ward
Vaccination Adult Vaccination Geriatric Medicine Public Palliative Medicine Vaccines 4 Life Program
Susan Bain, DRSc
Assistant Professor of Regulatory and Quality Sciences · USC School of Pharmacy
Susan Bain is an accomplished quality and regulatory professional with experience in the medical device and pharmaceutical industries.
Regulatory and Quality Sciences Biotechnology Industries Pharmaceutical Medical Devices
Stephen Mayfield
Director, California Center for Algae Biotechnology Co-director, Food & Fuel for the 21st Century Professor · UC San Diego
Stephen Mayfield's research analyses the structures and proteins in algae.
Pharmaceuticals Biofuel Algae Molecular Genetics Protein Biochemistry
Dr. Mine Durusu-Tanriover
Professor of Internal Medicine · Hacettepe University
Prof Mine Durusu Tanriover works closely with regional and global scientific community on adult vaccination, influenza and COVID-19.
Acute Care Quality Improvement Vaccines 4 Life Program Influenza Vaccination
James K. Ferri, Ph.D.
Professor and Associate Chair, Department of Chemical and Life Science Engineering · VCU College of Engineering
Dr. Ferri is a Professor in the Department of Chemical and Life Science Engineering at VCU
Advanced Manufacturing Stability in disperse systems Interfacial Phenomena Process intensification
Seth Seabury, PhD
Associate Professor of Pharmaceutical and Health Economics · USC School of Pharmacy
Seth Seabury is an expert in the impact of health on productivity and the law impact delivery of care and patient outcomes.
Value of Innovative Treatments Pharmaceutical and Health Economics Health Care Policy Delivery of Care and Patient Outcomes Medical Care Spending
Shawn (Sheng-Chieh) Chen
Assistant Professor, Department of Mechanical and Nuclear Engineering · VCU School of Engineering
Shawn's research interests include airborne and liquid-borne nanoparticle filtration, NanoEHS, and indoor and urban air pollution control.
CFD simulation Indoor Air Quality Aerosol sampling and instrumentation Air pollution control Nanofiltration and ultrafiltration
Wujie Zhang, Ph.D.
Associate Professor · Milwaukee School of Engineering
Dr. Wujie Zhang is an expert in biomaterials, tissue engineering, stem cell-based medicine, micro/nanotechnology, and drug delivery.
Biomaterials Regenerative Medicine and Tissue Engineering Micro/Nano-technology Drug Delivery Stem Cell Research
Terri Corbo, Pharm.D., MHCDS, FASHP
Senior Vice President of Clinical Essential Services · ChristianaCare
Terri Corbo is an expert in pharmacy and value-driven healthcare operations.
Healthcare Operations Pharmacy Services Clinical Essential Services Clinical Pharmacy
Stan Gee Louie, PharmD
Professor of Clinical Pharmacy & Director of Clinical Experimental Therapeutics Program · USC School of Pharmacy
Stan Gee Louie is a clinical and translational pharmacologist with three decades of clinical and drug development experience.
Accelerating wound healing properties Developing novel drug therapy to inhibit chronic inflammation in cancer, diabetes, and neurodegenerative disease. Drug development targeting viral infection and cancer. Metabolomic approaches to dissecting the molecular mechanism(s) driving pharmacologic responses.
Seema Nagpal
Epidemiologist and Senior Leader, Public Policy · Diabetes Canada
Seema Nagpal is an epidemiologist with broad experience in research and policy
Diabetes Epidemiology Strategic Planning Clinical Research Program Evaluation
Dr Afzal-Ur-Rahman Mohammed
Professor, Pharmacy · Aston University
Afzal-Ur-Rahman Mohammed's research interests include formulation development and optimization of orally disintegrating tablets.
Dry Particle Coating Technology Tablets Pharmacy Pharmaceuticals Stability Testing
Tani Chen
Patent Attorney · Wolf Greenfield
Tani Chen counsels clients in IP protection across a variety of areas including nanotechnology, chemical processes, and analytical devices.
Pharmaceutical Chemical & Materials Technologies Intellectual Property Protection Intellectual Property Biotechnology
Lisa Holle, Pharm.D., BCOP, FHOPA
Associate Clinical Professor of Pharmacy Practice · University of Connecticut
Dr. Holle’s clinical research focuses on medical marijuana, oral cancer therapy management, and impact of clinical pharmacy services
MyDispense Medical Marijuana Pain Cancer Cancer Therapeutics
Paul Jansen
Consultant, Board Member and Advisor · Haselmeier Group
Paul Jansen is an experienced pharmaceutical industry professional with expertise in drug and biologics device development.
Biotechnology Pharmaceutical Industry Drug Development Biologics Device Development Product Launch
Frank Baumgartner, Ph.D.
Richard J. Richardson Distinguished Professor, Department of Political Science, College of Arts and Sciences · UNC-Chapel Hill
Research: public policy, agenda-setting, interest groups in American politics, the death penalty and racial profiling in traffic stops.
Race and Profiling Public Policy Death Penalty Interest groups in American politics Agenda-setting
Gerry Brunk
Managing Director · Lumira Ventures
Gerry Brunk is a venture capital investor with expertise in biotechnology, medical devices, start-ups and corporate strategy.
Business Strategy Medical Devices Pharmaceutical Industry Drug Development Commercialization